Medicare Enrolled
Dr. Philip Brodak, MD
Urology Physician · Murrieta, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brodak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brodak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brodak
Dr. Philip Brodak is an urology physician in Murrieta, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brodak performed 65,412 Medicare services across 3,818 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brodak received a total of $23,998 from 66 pharmaceutical and/or device companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brodak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$23,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗65,412
Medicare services
Top 3% in CA for urology physician
3,818
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,443 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
49,506 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 6,840 | $19 | $47 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
2,160 | $0 | $1 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,529 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,430 | $97 | $268 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,283 | $9 | $23 |
| Leuprolide injectable, camcevi, 1 mg | 588 | $60 | $153 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
396 | $76 | $298 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $65 | $189 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
163 | $11 | $30 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
156 | $196 | $518 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
154 | $53 | $163 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $120 | $348 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 93 | $138 | $354 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
77 | $6 | $30 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
77 | $22 | $56 |
| Complicated insertion of bladder tube | 74 | $122 | $320 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $138 | $375 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
64 | $75 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $41 | $119 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
51 | $19 | $50 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
46 | $108 | $290 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $27 | $73 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
45 | $298 | $788 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
33 | $27 | $136 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
32 | $323 | $833 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
32 | $164 | $418 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
30 | $43 | $132 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
21 | $300 | $770 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
13 | $597 | $1,665 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $85 | $235 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $141 | $348 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,998
Total received (2018-2024)
Avg $3,428/year across 7 years
Top 11% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
494
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,072 (54.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,470 (43.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$455 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,885
2023
$4,307
2022
$2,169
2021
$4,009
2020
$2,736
2019
$2,848
2018
$6,045
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$459
Endo USA, Inc.
$246
Dendreon Pharmaceuticals LLC
$187
Antares Pharma, Inc.
$140
Boston Scientific Corporation
$122
Janssen Biotech, Inc.
$87
ABBVIE INC.
$87
ACCORD HEALTHCARE, INC.
$68
UROGEN PHARMA, INC.
$61
IMMUNITYBIO, INC.
$50
Myriad Genetic Laboratories, Inc.
$50
Teleflex LLC
$42
Axonics, Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$38
Astellas Pharma US Inc
$34
Endo Pharmaceuticals Inc.
$32
Laborie Medical Technologies Corp.
$29
Ferring Pharmaceuticals Inc.
$26
PFIZER INC.
$22
COLOPLAST CORP
$21
Sumitomo Pharma America, Inc.
$20
Becton, Dickinson and Company
$20
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$5,488
Astellas Pharma US Inc
$3,397
Avadel Specialty Pharmaceuticals, LLC
$2,525
NeoTract Inc.
$2,365
Dendreon Pharmaceuticals LLC
$1,140
Coloplast Corp
$962
Janssen Biotech, Inc.
$839
PFIZER INC.
$659
PROCEPT BioRobotics Corporation
$585
Antares Pharma, Inc.
$461
Myriad Genetic Laboratories, Inc.
$322
Boston Scientific Corporation
$319
ABBVIE INC.
$309
Allergan, Inc.
$293
Sumitomo Pharma America, Inc.
$256
Endo Pharmaceuticals Inc.
$247
Endo USA, Inc.
$246
Medtronic USA, Inc.
$245
Laborie Medical Technologies Corp.
$212
Teleflex LLC
$196
ACCORD HEALTHCARE, INC.
$191
Caldera Medical, Inc
$185
COLOPLAST CORP
$160
Duchesnay USA Incorporated
$159
AbbVie, Inc.
$156
Amgen Inc.
$154
AbbVie Inc.
$130
UroGen Pharma, Inc.
$120
Supernus Pharmaceuticals, Inc.
$111
Axonics, Inc.
$108
Verity Pharmaceuticals Inc.
$98
Ferring Pharmaceuticals Inc.
$95
Medtronic, Inc.
$92
Intuitive Surgical, Inc.
$91
AstraZeneca Pharmaceuticals LP
$83
Myovant Sciences Inc.
$77
Sun Pharmaceutical Industries Inc.
$73
BioTissue Holdings, Inc.
$69
UROGEN PHARMA, INC.
$61
Davol Inc.
$57
IMMUNITYBIO, INC.
$50
Zyla Life Sciences
$47
Olympus America Inc.
$41
Alnylam Pharmaceuticals Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$38
Novartis Pharmaceuticals Corporation
$38
AMAG Pharmaceuticals, Inc.
$38
Allergan Inc.
$30
Blue Earth Diagnostics Limited
$29
Foundation Medicine, Inc.
$29
Ethicon US, LLC
$27
Progenics Pharmaceuticals, Inc.
$24
Smith+Nephew, Inc.
$24
Merck Sharp & Dohme LLC
$23
BAXTER HEALTHCARE
$21
Becton, Dickinson and Company
$20
Aytu BioScience, Inc
$18
Palette Life Sciences, Inc.
$17
DENTSPLY IH Inc.
$16
Telix Pharmaceuticals
$15
Retrophin, Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$14
TherapeuticsMD, Inc.
$13
Integra LifeSciences Corporation
$13
BK Medical Holding Company Inc.
$11
NxThera, Inc.
$8
Top 3 companies account for 47.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ALTIS · AMS 700 CXR RTE Kit · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FlexiTip · AVEED · AXIS · AdVance XP · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOFIX · BOTOX · CAMCEVI · COLOGUARD · Da Vinci Surgical System · Desara · ECHELON FLEX Stapler · EDEX · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · ILLUCCIX · IMVEXXY · INTERSTIM · INTRAROSA · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus Cystoscopes · Optilume BPH Drug Coated Balloon Catheter · Osphena · Otrexup · PLUVICTO · PREMARIN · PROLARIS · PROVENGE · PVC · PYLARIFY · Porges Coloplast · Prolia · REZUM · Rezum · SOLESTA · SPRIX · STRAVIX · Solyx SIS System · SpeediCath · TISSEEL · TITAN · TLANDO · TOPOTECAN · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
39
Per 100K population
1.6
County median income
$89,672
Nearest hospital
SOUTHWEST HEALTHCARE RANCHO SPRINGS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brodak is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brodak experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Brodak performed 49,506 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brodak receive payments from pharmaceutical companies?
Yes. Dr. Brodak received a total of $23,998 from 66 companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brodak's costs compare to other urology physicians in Murrieta?
Dr. Brodak's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brodak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Murrieta
Browse urology physicians in Murrieta ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Avadel Specialty Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Avadel Specialty Pharmaceuticals, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology